Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytotoxic gigantecin analogue presented at ACS meeting

Sep. 3, 1998

WHI reports design, synthesis and pharmacological evaluation of new agent for glioblastoma

Sep. 3, 1998

FDA advisory committee recommends clearance for Valstar

Sep. 3, 1998

Nolvadex recommended for approval in U.S., to be copromoted by Zeneca and Roche

Sep. 3, 1998

Antitumor imidazoacridone available for licensing from BTG

Sep. 3, 1998

Protegrin analogue safe in cancer patients receiving chemotherapy

Sep. 3, 1998

Novartis describes search for potent and selective CDK1/CDK2 inhibitors

Sep. 2, 1998

AEterna isolates molecule exhibiting anti-MMP activity

Sep. 2, 1998

Orphan drug designation granted for thalidomide in KS

Sep. 1, 1998

News from the ACS: Btk inhibitor LFM-A13 promotes apoptosis in leukemia cells

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.